Roxybond

Acute Pain, Pain, Pain + 2 more

Treatment

5 FDA approvals

0 Active Studies for Roxybond

What is Roxybond

Oxycodone

The Generic name of this drug

Treatment Summary

Oxycodone is a type of painkiller derived from thebaine, a naturally occurring opioid. It is used to treat moderate to severe pain on a short-term or long-term basis. The first oxycodone product, Percodan, was approved by the FDA in 1950.

Percodan

is the brand name

Roxybond Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Percodan

Oxycodone

1950

822

Approved as Treatment by the FDA

Oxycodone, otherwise called Percodan, is approved by the FDA for 5 uses like Pain and Acute Pain .

Pain

Used to treat Severe Pain in combination with Acetaminophen

Acute Pain

Helps manage acute, moderate Pain

Pain

Helps manage Severe, Chronic Pain

Pain

Helps manage chronic, moderate Pain

Pain

Helps manage severe Pain, Acute

Effectiveness

How Roxybond Affects Patients

Oxycodone has effects on many parts of the body, including the brain stem, cough reflex, pupils, digestive system, blood vessels, hormones, and immune system. It can cause breathing to slow down, decrease the size of the pupils, slow digestion and cause constipation, cause itching, red eyes, flushing and sweating, change hormone levels, and possibly affect the immune system.

How Roxybond works in the body

Oxycodone works by targeting opioid receptors in your body, specifically in the brain, heart, lungs, liver, gastrointestinal tract, and reproductive system. These receptors are increased in conditions of inflammation or pain. Oxycodone and its active metabolites bind to these receptors and activate a G protein-coupled receptor signaling pathway. This pathway blocks N-type voltage operated calcium channels and stops your body from responding to pain.

When to interrupt dosage

The proposed measure of Roxybond is contingent upon the diagnosed condition, such as severe, average Pain, Pain and Pain. The exact quantity of dosage fluctuates, in accordance with the method of delivery (e.g. Concentrate - Oral or Oral) referenced in the table beneath.

Condition

Dosage

Administration

Acute Pain

, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL

Capsule - Oral, , Solution, Solution - Oral, Oral, Capsule, Tablet, Tablet - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated - Oral, Tablet, film coated, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Capsule, gelatin coated, Concentrate, Concentrate - Oral

Pain

, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL

Capsule - Oral, , Solution, Solution - Oral, Oral, Capsule, Tablet, Tablet - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated - Oral, Tablet, film coated, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Capsule, gelatin coated, Concentrate, Concentrate - Oral

Pain

, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL

Capsule - Oral, , Solution, Solution - Oral, Oral, Capsule, Tablet, Tablet - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated - Oral, Tablet, film coated, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Capsule, gelatin coated, Concentrate, Concentrate - Oral

Pain

, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL

Capsule - Oral, , Solution, Solution - Oral, Oral, Capsule, Tablet, Tablet - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated - Oral, Tablet, film coated, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Capsule, gelatin coated, Concentrate, Concentrate - Oral

Pain

, 100.0 mg/mL, 5.0 mg/mL, 5.0 mg, 15.0 mg, 30.0 mg, 4.8355 mg, 10.0 mg, 2.5 mg, 7.5 mg, 20.0 mg, 40.0 mg, 80.0 mg, 60.0 mg, 20.0 mg/mL, 9.0 mg, 13.5 mg, 18.0 mg, 27.0 mg, 36.0 mg, 160.0 mg, 4.5 mg, 2.25 mg, 4.88 mg, 10.0 mg/mL

Capsule - Oral, , Solution, Solution - Oral, Oral, Capsule, Tablet, Tablet - Oral, Capsule, gelatin coated - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, coated, Tablet, coated - Oral, Tablet, film coated - Oral, Tablet, film coated, Solution, concentrate, Solution, concentrate - Oral, Tablet, extended release, Tablet, extended release - Oral, Rectal, Suppository, Suppository - Rectal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, extended release, Capsule, extended release - Oral, Capsule, gelatin coated, Concentrate, Concentrate - Oral

Warnings

Roxybond Contraindications

Condition

Risk Level

Notes

Intestinal Obstruction

Do Not Combine

Paralytic Ileus

Do Not Combine

Intestinal Pseudo-Obstruction

Do Not Combine

Intestinal Obstruction

Do Not Combine

Mental Depression

Do Not Combine

Asthma

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Oxycodone may interact with Pulse Frequency

There are 20 known major drug interactions with Roxybond.

Common Roxybond Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Oxycodone.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Oxycodone.

Azelastine

Major

Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Oxycodone.

Carbamazepine

Major

The metabolism of Carbamazepine can be decreased when combined with Oxycodone.

Roxybond Toxicity & Overdose Risk

Taking too much oxycodone can lead to breathing problems, drowsiness, unconsciousness, weak muscles, cold sweats, small pupils, slow heartbeat, low blood pressure, difficulty breathing, snoring, and even death. Treatment includes maintaining airways and oxygen levels, using oxygen and medication to treat shock and fluid in the lungs, and using drugs such as Naloxone to counteract the effects of opioids. Pregnant women should use caution when taking oxycodone as animal studies have shown smaller offspring with lactation. Oxycodone is not known to cause cancer, but has been found to be genotoxic in some tests

Roxybond Novel Uses: Which Conditions Have a Clinical Trial Featuring Roxybond?

No active clinical trials are currently being conducted to investigate the ability of Roxybond to provide relief from acute, moderate Pain and Pain.

Condition

Clinical Trials

Trial Phases

Pain

0 Actively Recruiting

Acute Pain

0 Actively Recruiting

Pain

0 Actively Recruiting

Pain

0 Actively Recruiting

Pain

0 Actively Recruiting

Patient Q&A Section about roxybond

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.